Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: Influence of long-term treatment with the antidepressant moclobemide

Neuroscience

Volumn 85, Issue 2, 1998, Pages 415-425

  Sillaber, I ^a   Montkowski, A ^a   Landgraf, R ^a   Barden, N ^b   Holsboer, F ^a   Spanagel, R ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antidepressant treatment; Hypothalamic pituitary adrenocortical system; In vivo microdialysis; Mesolimbic system; Mice; Morphine

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; CORTICOSTERONE; DOPAMINE; GLUCOCORTICOID RECEPTOR; HOMOVANILLIC ACID; MESSENGER RNA; MOCLOBEMIDE; MORPHINE; SEROTONIN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; LOCOMOTION; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEROTONIN RELEASE; TRANSGENIC MOUSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZAMIDES; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOPAMINE; LOCOMOTION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRODIALYSIS; MOCLOBEMIDE; MORPHINE; NUCLEUS ACCUMBENS; RECEPTORS, GLUCOCORTICOID; SEROTONIN;

EID: 0032495862     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00607-6     Document Type: Article

References (51)

1. Alexander B. K., Coambs R. B., Hadaway P. F. The effect of housing and gender on morphine self-administration in rats. Psychopharmacology. 58:1978;175-179.
2. Azmitia E. C. Jr., McEwen B. S. Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat. Science. 166:1969;1274-1276.
3. Barden N., Reul J. M. H. M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
4. Barden N. Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry. 29:1996;12-22.
5. Barden N., Stec I. S. M., Montkowski A., Holsboer F., Reul J. M. H. M. Endocrine profile and neuroendocrine challenge test in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology. 66:1997;212-220.
6. Cador M., Dulluc J., Mormède P. Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience. 56:1993;981-988.
7. 3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmac. 164:1989;515-519.
8. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Rev. 18:1993;1-32.
9. Colzi A., d'Agostini F., Cesura A. M., Da Prada M. Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant. Psychopharmacology. 106:1992;17-20.
10. de Kloet E. R., Kovacs G. L., Szabo G., Telegdy G., Bohus B., Versteeg D. H. G. Decreased serotonin turnover in the dorsal hippocampus of the rat brain shortly after adrenalectomy: selective normalisation after corticosterone substitution. Brain Res. 239:1982;659-663.
11. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. natn. Acad. Sci. U.S.A. 85:1988;5274-5278.
12. Fahlke C., Hard E., Hansen S. Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology. 127:1996;133-139.
13. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic, San Diego.
14. Goeders N. E., Guerin G. F. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 64:1996;337-348.
15. Haefely W., Burkard W. P., Cesura A. M., Kettler R., Lorez H. P., Martin J. R., Richards J. G., Scherschlicht R., Da Prada M. Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology. 106:1992;6-14.
16. Haney M., Maccari R., Le Moal M., Simon H., Piazza P. V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res. 698:1995;46-52.
17. Härfstrand A., Fuxe K., Cintra A., Agnati L. F., Zini I., Wilkström A. C., Okret S., Yu Z. Y., Goldstein M., Steinbusch H., Verhofstad A., Gustafsson J. A. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9779-9783.
18. Herve D., Pickel V. M., Joh T. H., Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:1987;71-83.
19. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
20. Hooks M. S., Colvin A. C., Juncos J. L., Justice J. B. Jr. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 587:1992;306-312.
21. Joels M., de Kloet E. R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43:1994;1-36.
22. Karanth A., Linthorst A. C. E., Stalla G. K., Barden N., Holsboer F., Reul J. M. H. M. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology. 138:1997;3476-3485.
23. Landgraf R., Neumann I., Holsboer F., Pittman Q. J. Interleukin-1β stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur. J. Neurosci. 7:1995;592-598.
24. Maccari S., Piazza P. V., Deminière J. M., Lemaire V., Mormède P., Simon H., Angelucci L., Le Moal M. Life events-induced decrease of type I corticosteroid receptors is associated with reduced corticosterone feedback and enhanced vulnerability to amphetamine self-administration. Brain Res. 547:1991;7-12.
25. Marinelli M., Piazza P. V., Deroche V., Maccari S., Le Moal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J. Neurosci. 14:1994;2724-2731.
26. Marinelli M., Rougé-Pont F., De Jesus-Oliveira C., Le Moal M., Piazza P. V. Acute blockade of corticosterone secretion decreases the psychomotor stimulant effects of cocaine. Neuropsychopharmacology. 16:1997;156-161.
27. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J. M. H. M., Landgraf R., Holsboer F. Long-term antidepressant treatment reduces behavioral deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7:1995;841-845.
28. 3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur. J. Pharmac. 230:1993;63-68.
29. Pepin M. C., Beaulieu S., Barden N. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neural cultures. Molec. Brain Res. 6:1989;77-83.
30. Pepin M. C., Pothier F., Barden N. Impaired type II glucocorticoid receptor function in mice bearing antisense RNA transgene. Nature. 355:1992;725-728.
31. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
32. Piazza P. V., Maccari S., Deminière J. M., Le Moal H., Mormède P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. natn. Acad. Sci. U.S.A. 88:1991;2089-2092.
33. Piazza P. V., Rougé-Pont F., Deminière J. M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567:1991;169-174.
34. Piazza P. V., Marinelli M., Jodogne C., Deroche V., Rougé-Pont F., Maccari S., Le Moal M., Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658:1994;259-264.
35. Piazza P. V., Rougé-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. natn. Acad. Sci. U.S.A. 93:1996;8716-8720.
36. Piazza P. V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. A. Rev. Pharmac. Toxicol. 36:1996;359-378.
37. Piazza P. V., Barrot M., Rougé-Pont F., Marinelli M., Maccari S., Abrous D. N., Simon H., Le Moal M. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. natn. Acad. Sci. U.S.A. 93:1996;15445-15450.
38. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmac. exp. Ther. 271:1994;83-90.
39. Reul J. M. H. M., Labeur M. S., Grigoriadis D. E., De Souza E. B., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
40. Ronken E., Mulder A. H., Schoffelmeer A. N. M. Glucocorticoid and mineralocorticoid receptors differentially modulate cultured dopaminergic neurons of rat ventral mesencephalon. Eur. J. Pharmac. 263:1994;149-156.
41. Rougé-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P. V. Stress-induced sensitization and glucocorticoids II: sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7189-7195.
42. Schenk S., Gorman K., Amit Z. Age-dependent effects of isolation housing on the self-administration of ethanol in laboratory rats. Alcohol. 7:1990;321-326.
43. Shaham Y., Stewart J. Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats. Psychopharmacology. 114:1994;523-527.
44. Shoaib M., Spanagel R., Stöhr T., Shippenberg T. S. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology. 117:1995;240-247.
45. Singh V. B., Corley K. C., Phan T., Boadle-Biber M. C. Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res. 516:1990;66-76.
46. Spanagel R., Herz A., Shippenberg T. S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
47. Spanagel R., Stöhr T., Barden N., Holsboer F. Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 8:1996;93-97.
48. Spanagel R. (1996). Involvement of multiple opioidergic systems in dopamine pharmacology. In CNS Neurotransmitters and Neuromodulators: Dopamine, (ed. Stone T. W.), pp. 201-212. CRC, Boca Raton, FA.
49. Stec I., Barden N., Reul J. M. H. M., Holsboer F. Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J. psychiatr. Res. 28:1994;1-5.
50. Wise R. A., Rompre P. P. Brain dopamine and reward. A. Rev. Psychol. 40:1989;191-225.
51. Yadid G., Pacak K., Kopin I. J., Goldstein D. S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmac. exp. Ther. 270:1994;1158-1165.